Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$636M |
| 2 |
UnitedHealth
UNH
|
+$635M |
| 3 |
Estee Lauder
EL
|
+$632M |
| 4 |
AbbVie
ABBV
|
+$466M |
| 5 |
PayPal
PYPL
|
+$451M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
O'Reilly Automotive
ORLY
|
+$559M |
| 2 |
SHPG
Shire pic
SHPG
|
+$464M |
| 3 |
Amazon
AMZN
|
+$458M |
| 4 |
Ulta Beauty
ULTA
|
+$439M |
| 5 |
Alibaba
BABA
|
+$397M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.96% |
| 2 | Healthcare | 15.31% |
| 3 | Consumer Discretionary | 14.83% |
| 4 | Communication Services | 12.99% |
| 5 | Financials | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Celanese
CE
$4.95B
| $21.1M | 0.02% |
201,879
-9,980
| -5% | -$981K |
|
402
Alkermes
ALKS
$8.81B
| $20.4M | 0.02% |
401,068
-2,099
| -0.5% | -$112K |
|
403
XPO
XPO
$24.1B
| $20.3M | 0.02% |
+867,418
| New | +$18.2M |
|
|
MULE
404
DELISTED
MuleSoft, Inc.
MULE
| $20.3M | 0.02% |
1,007,185
+444,262
| +79% | +$9.9M |
|
405
MaxLinear
MXL
$5.75B
| $20.2M | 0.02% |
849,739
+19,585
| +2% | +$471K |
|
406
Neurocrine Biosciences
NBIX
$17.8B
| $19.7M | 0.02% |
321,145
-971
| -0.3% | -$51.2K |
|
407
Constellium
CSTM
$3.95B
| $19.6M | 0.02% |
1,916,142
-1,807,627
| -49% | -$17.1M |
|
408
Cousins Properties
CUZ
$5.3B
| $19.5M | 0.02% |
522,995
-2,796
| -0.5% | -$102K |
|
409
Wayfair
W
$11.9B
| $19.4M | 0.02% |
287,374
-58,904
| -17% | -$4.37M |
|
410
Toll Brothers
TOL
$14.2B
| $19.2M | 0.02% |
463,101
-1,066,178
| -70% | -$41.9M |
|
411
JELD-WEN Holding
JELD
$97.4M
| $19.2M | 0.02% |
539,898
+251,803
| +87% | +$7.97M |
|
412
CoStar Group
CSGP
$12B
| $18.8M | 0.02% |
+702,110
| New | +$19.5M |
|
|
GLDD
413
DELISTED
Great Lakes Dredge & Dock
GLDD
| $18.7M | 0.02% |
3,857,232
+2,918
| +0.1% | +$12.2K |
|
414
Laureate Education
LAUR
$5.15B
| $18.6M | 0.02% |
1,277,933
-9,803
| -0.8% | -$154K |
|
|
ZEN
415
DELISTED
ZENDESK INC
ZEN
| $18.4M | 0.02% |
633,651
-18,939
| -3% | -$532K |
|
416
Target
TGT
$63.7B
| $18.4M | 0.02% |
311,648
-184,990
| -37% | -$10.4M |
|
417
Ultragenyx Pharmaceutical
RARE
$2.64B
| $18M | 0.02% |
338,509
-131,523
| -28% | -$7.79M |
|
418
Antero Midstream
AM
$10.6B
| $18M | 0.02% |
880,159
-878,033
| -50% | -$17.5M |
|
|
AVXS
419
DELISTED
AveXis, Inc. Common Stock
AVXS
| $17.8M | 0.02% |
184,211
-457
| -0.2% | -$41.2K |
|
420
Range Resources
RRC
$9.02B
| $17.7M | 0.02% |
903,893
-54,869
| -6% | -$1.06M |
|
|
AEUA
421
DELISTED
Anadarko Petroleum Corporation
AEUA
| $17.7M | 0.02% |
444,144
+82,354
| +23% | +$3.17M |
|
|
POT
422
DELISTED
Potash Corp Of Saskatchewan
POT
| $17.4M | 0.02% |
906,824
-51,964
| -5% | -$926K |
|
|
ZOES
423
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $17.2M | 0.02% |
1,363,846
-573,437
| -30% | -$6.99M |
|
|
INN
424
Summit Hotel Properties
INN
$753M
| $17M | 0.02% |
1,065,842
+17,322
| +2% | +$281K |
|
|
BPL
425
DELISTED
Buckeye Partners, L.P.
BPL
| $16.9M | 0.02% |
297,155
+31,201
| +12% | +$1.85M |
|
Similar funds
Jennison Associates's Q3 2017 Portfolio in Review
As of Q3 2017, Jennison Associates held 727 positions worth $97.6B, up 3.6% from $94.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jennison Associates withdrew a net $3.38B in Q3 2017, closing 79 positions and reducing 330 holdings. Its most notable exit was O'Reilly Automotive, an estimated $559M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in Estee Lauder worth $664M.
- Jennison Associates's largest Q3 2017 buy was Estee Lauder: 6,161,274 shares worth $664M.
- Jennison Associates added most to Alexion Pharmaceuticals in Q3 2017, an estimated $636M increase.
- Jennison Associates's biggest Q3 2017 reduction was Shire pic, cutting an estimated $464M.
- Jennison Associates fully exited O'Reilly Automotive in Q3 2017, selling an estimated $559M.
- Jennison Associates's ten largest holdings make up 28% of its $97.6B portfolio in Q3 2017.
- Jennison Associates opened 90 new positions and closed 79 in Q3 2017.
- Jennison Associates's portfolio value rose 3.6% quarter-over-quarter to $97.6B.
Based on Jennison Associates's 13F filing for Q3 2017, filed 3 Nov 2017.